TYPE 2 DIABETES MELLITUS IN PATIENTS WITH SCHIZOPHRENIA: THE EFFECT OF (POLY)GENETIC RISK SCORE OF SCHIZOPHRENIA AND TYPE 2 DIABETES AND ANTIPSYCHOTIC MEDICATION USE

Tesfa Habtewold; Richard Bruggeman; Edith J. Liemburg; Md. Atiqul Islam; Behrooz Z. Alizadeh

doi:10.1016/j.euroneuro.2018.08.493

TYPE 2 DIABETES MELLITUS IN PATIENTS WITH SCHIZOPHRENIA: THE EFFECT OF (POLY)GENETIC RISK SCORE OF SCHIZOPHRENIA AND TYPE 2 DIABETES AND ANTIPSYCHOTIC MEDICATION USE

Tesfa Habtewold, Richard Bruggeman, Edith J. Liemburg, Md. Atiqul Islam, Behrooz Z. Alizadeh

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	1335
Number of pages	1
Journal	European Neuropsychopharmacology
Volume	29
DOIs	https://doi.org/10.1016/j.euroneuro.2018.08.493
Publication status	Published - 2019
Event	26th World Congress of Psychiatric Genetics (WCPG) - Glasgow Duration: 11-Oct-2018 → 15-Oct-2018

Access to Document

10.1016/j.euroneuro.2018.08.493

Handle.net

Persistent link

Cite this

@article{91449b626218436cb8e8000489e68a4d,

title = "TYPE 2 DIABETES MELLITUS IN PATIENTS WITH SCHIZOPHRENIA: THE EFFECT OF (POLY)GENETIC RISK SCORE OF SCHIZOPHRENIA AND TYPE 2 DIABETES AND ANTIPSYCHOTIC MEDICATION USE",

author = "Tesfa Habtewold and Richard Bruggeman and Liemburg, {Edith J.} and Islam, {Md. Atiqul} and Alizadeh, {Behrooz Z.}",

year = "2019",

doi = "10.1016/j.euroneuro.2018.08.493",

language = "English",

volume = "29",

pages = "1335",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "ELSEVIER SCIENCE BV",

note = "26th World Congress of Psychiatric Genetics (WCPG) ; Conference date: 11-10-2018 Through 15-10-2018",

}

TY - JOUR

T1 - TYPE 2 DIABETES MELLITUS IN PATIENTS WITH SCHIZOPHRENIA

T2 - 26th World Congress of Psychiatric Genetics (WCPG)

AU - Habtewold, Tesfa

AU - Bruggeman, Richard

AU - Liemburg, Edith J.

AU - Islam, Md. Atiqul

AU - Alizadeh, Behrooz Z.

PY - 2019

Y1 - 2019

U2 - 10.1016/j.euroneuro.2018.08.493

DO - 10.1016/j.euroneuro.2018.08.493

M3 - Meeting Abstract

SN - 0924-977X

VL - 29

SP - 1335

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

Y2 - 11 October 2018 through 15 October 2018

ER -